Bio Rad Laboratories

Bio Rad Laboratories Gross Margin

The Gross Margin of Bio Rad Laboratories (BIO) as of Oct 1, 2026 is 52.01 %. In the previous year, Gross Margin was 53.73 % — a change of -3.19% (lower).

Gross Margin

52.01 %

YoY

-3.19%

Last updated:

Gross Margin of Bio Rad Laboratories is 2026 52.01 % . Gross Margin of Bio Rad Laboratories was 2025 53.73 % . It decreases by -3.19% lower compared to the previous year.

Bio Rad Laboratories's gross margin stands at 52.0%, down from 56.1% several years earlier.

The Bio Rad Laboratories Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
53.46 USD
Jan 1, 2019
54.38 USD
Jan 1, 2020
56.48 USD
Jan 1, 2021
56.05 USD
Jan 1, 2022
55.93 USD
Jan 1, 2023
53.42 USD
Jan 1, 2024
53.73 USD
Jan 1, 2025
52.01 USD
The Bio Rad Laboratories Gross Margin history
YEARGross MarginYoY
52.01 %-3.19%
53.73 %+0.58%
53.42 %-4.49%
55.93 %-0.21%
56.05 %-0.77%
56.48 %+3.88%
54.38 %+1.71%
53.46 %-2.74%
54.97 %-0.11%
55.03 %-0.93%
55.54 %+2.51%
54.18 %+9,705.62%
0.55 %-1.52%
0.56 %-1.23%
0.57 %+0.30%
0.57 %+1.07%
0.56 %+2.72%
0.55 %+0.72%
0.54 %-3.16%
0.56 %—
Access this data via the Eulerpool API

Bio Rad Laboratories Stock analysis

What does Bio Rad Laboratories do? Bio-Rad Laboratories Inc. is a leading company in the field of scientific research based in Hercules, California. The company was founded in 1952 by two brothers and has since developed into a multinational company with over 8,000 employees worldwide. Bio-Rad has branches in over 100 countries and its products are used in biotechnology, pharmaceuticals, and the food industry. History Bio-Rad was founded in 1952 by the couple David and Alice Schwartz. They started with the production of blood group serology tests and later expanded their product range to include immunchemicals, electrophoresis equipment, and antibodies. In the 1970s, Bio-Rad developed the first commercial protein A purification system, which is still an important component of protein research today. Business model Bio-Rad's business model is focused on providing high-quality products and services to support customers in their scientific research. The company has various divisions such as life science research, clinical diagnostics, and life science education, which offer products and solutions for scientists, researchers, and diagnosticians. Life science research The life science research division offers a wide range of products and services for biological research. This includes PCR systems, electrophoresis equipment, antibodies, proteins, cell counters, and much more. Bio-Rad's products are used by scientists and researchers around the world to better understand the intricacies of life and the mechanisms of diseases. Clinical diagnostics Bio-Rad's clinical diagnostics division provides a broad spectrum of diagnostic products and solutions for hospitals, laboratories, and medical facilities. The company provides clinical diagnostic instruments, reagents, testing systems, and software to support the diagnostic process. Life science education The life science education division offers innovative and interactive teaching and learning materials for scientific research to teachers, professors, and students. Bio-Rad's products and solutions support the better understanding of the intricacies of life and the mechanisms of diseases in the fields of biology, chemistry, and physics. Products Bio-Rad offers a wide range of products and solutions for research and diagnostics. These include, among others: PCR systems: Bio-Rad offers various PCR systems that help researchers and diagnosticians amplify and analyze DNA. The systems are highly precise and provide reliable results. Proteins and antibodies: Bio-Rad offers a wide selection of proteins and antibodies for research and diagnostics. The products include various types of proteins and antibodies needed for the analysis of protein functions and interactions. Electrophoresis equipment: Bio-Rad provides various electrophoresis equipment that plays an important role in research and diagnostics. The products include gel electrophoresis systems, Western blot systems, and devices for protein analysis. Clinical diagnostics: Bio-Rad offers a wide range of diagnostic products for hospitals, laboratories, and medical facilities. These include immunoassay products, blood group serology tests, and devices for the diagnosis of infectious diseases. In summary, Bio-Rad Laboratories Inc. is a leading company in the field of scientific research. The company offers a wide range of products and solutions for research and diagnostics, supporting scientists, researchers, and diagnosticians around the world in exploring the intricacies of life and better understanding diseases. Bio Rad Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Rad Laboratories stock

Gross Margin of Bio Rad Laboratories is 52.01 % in 2026.

Gross Margin of Bio Rad Laboratories changed from 53.73 % to 52.01 %, representing a -3.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Bio Rad Laboratories since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Bio Rad Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Bio Rad Laboratories

All Key Metrics — Bio Rad Laboratories